The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Leadership - Karyopharm Therapeutics; SeraCare
Research Funding - Apexigen (Inst); AstraZeneca (Inst); BioCad (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); Genmab (Inst); Genos (Inst); GlaxoSmithKline (Inst); Karyopharm Therapeutics (Inst); Merck (Inst); Mersana (Inst); MSD (Inst); Oncology Venture (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst); SeraCare (Inst); Sotio (Inst); Takeda (Inst); Tesaro (Inst); Tesaro/GSK (Inst); Ultimovacs (Inst); ZaiLa (Inst)
Other Relationship - Danish Society of Gynaecologic Oncology; European Society of Gynaecological Oncology; Global Clinical Lead ENGOT-OV16/NOVA niraparib; Global Clinical Lead ENGOT-EN6/Ruby; GCIG- Gynecologic Cancer Inter Grou
ENGOT-en11/GOG-3053/KEYNOTE-B21: Phase 3 study of pembrolizumab or placebo in combination with adjuvant chemotherapy with/without radiotherapy in patients with newly diagnosed high-risk endometrial cancer.
 
Toon Van Gorp
Consulting or Advisory Role - AstraZeneca (Inst); Eisai Europe (Inst); OncXerna Therapeutics (Inst)
Research Funding - Amgen (Inst); Roche (Inst)
Travel, Accommodations, Expenses - BMS (Inst); Immunogen (Inst); MSD/Merck (Inst); Novartis (Inst); Roche (Inst)
 
Mansoor Raza Mirza
No Relationships to Disclose
 
Alain Lortholary
Honoraria - AstraZeneca; clovis oncology; Roche; Tesaro/GSK; Tesaro/GSK
 
David Cibula
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Roche; Sotio
 
Axel Walther
Consulting or Advisory Role - Roche; Tesaro/GSK
Speakers' Bureau - Roche; Tesaro/GSK
Other Relationship - AstraZeneca; Tesaro
 
Antonella Savarese
Consulting or Advisory Role - Tesaro
Speakers' Bureau - Tesaro
Travel, Accommodations, Expenses - Tesaro
 
Maria Pilar Barretina-Ginesta
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Roche
Speakers' Bureau - AstraZeneca; MSD; PharmaMar; Roche; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; MSD; PharmaMar; Roche; Tesaro
 
Fırat Ortaç
No Relationships to Disclose
 
Christos Papadimitriou
Consulting or Advisory Role - Amgen; AstraZeneca; Genesis Pharma; Merck; MSD; Novartis; Roche
Speakers' Bureau - Amgen; AstraZeneca; Genesis Pharma; Merck; MSD; Novartis; Roche
Research Funding - Bristol-Myers Squibb; Roche
 
Lubomir Bodnar
Consulting or Advisory Role - Bristol-Myers Squibb; Roche
Other Relationship - Bristol-Myers Squibb; Roche
 
Chyong-Huey Lai
Honoraria - ACT Genomics
Other Relationship - Roche
 
Jacob Korach
Consulting or Advisory Role - AstraZeneca; MSD Oncology
 
Christian Marth
Honoraria - AstraZeneca; GlaxoSmithKline; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; MSD; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Roche
 
Kosei Hasegawa
Honoraria - AstraZeneca; Bayer Yakuhin; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Eisai; MSD K.K
Consulting or Advisory Role - Kaken Pharmaceutical; MSD K.K
Research Funding - Daiichi Sankyo; Ono Pharmaceutical; Takeda
 
Xing Xie
No Relationships to Disclose
 
Emma L. Barber
Research Funding - GOG Foundation; Lilly; NIH
 
Robert L. Coleman
Employment - US Oncology
Stock and Other Ownership Interests - McKesson
Consulting or Advisory Role - Abbvie; Abbvie/Stemcentrx; Agenus; AstraZeneca/MedImmune; Clovis Oncology; Esperance Pharmaceuticals; Genentech/Roche; Genmab; Immunogen; Novocure; Oncolytics; OncoMed; OncoSec; Sotio; Tesaro
Research Funding - Abbott/AbbVie; Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Esperance Pharmaceuticals; Johnson & Johnson; Merck; OncoMed; Roche/Genentech
Travel, Accommodations, Expenses - Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Clovis Oncology; GOG Foundation; Merck; Research to Practice; Roche/Genentech; Sotio; Vaniam Group
 
Stephen Michael Keefe
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Robert Orlowski
Employment - MSD
Stock and Other Ownership Interests - Merck
 
Brian Slomovitz
Consulting or Advisory Role - Agenus; AstraZeneca; Clovis Oncology; Eisai; Genentech; GlaxoSmithKline; GOG Foundation; Incyte; Merck; Myriad Genetics